Hydralazine
Product Images NDC 75834-126

4 FDA label images from Nivagen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine (NDC 75834-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydralazine 01)

Chemical Structure (Hydralazine 01)
Chemical structure of Hydralazine Hydrochloride, showing the hydrazine group (NHNH2) attached to a dihydrophthalazine ring system with the hydrochloride (HCl) indicated.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
Hydralazine Hydrochloride Tablets USP 25 mg label showing a package size of 100 tablets. The label includes storage instructions, refill caution, and manufacturer details. It is manufactured by Cadila Pharmaceuticals Ltd. and distributed by Nivagen Pharmaceuticals, Inc. The label features the Nivagen Pharmaceuticals logo and a barcode.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Hydralazine Hydrochloride Tablets USP 50 mg packaging label showing the product name, strength, and form. The label indicates a quantity of 100 tablets and includes the NDC code 75834-127-01. Manufacturer information lists Nivagen Pharmaceuticals, Inc. and Cadila Pharmaceuticals Ltd. Dosage, storage instructions, and safety warnings are also visible on the label.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Label for Hydralazine Hydrochloride Tablets USP 100 mg by Nivagen Pharmaceuticals, Inc. The label states the product contains 100 tablets, includes NDC 75834-128-01, and has dosage storage and dispensing instructions. The label also includes barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.